Yuxiang Dong

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

ACS infectious diseases

Hepatology (Baltimore, Md.)

The Journal of organic chemistry

Journal of medicinal chemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Dalton W Staller, Sanjali S Panigrahi, Yahani P Jayasinghe, Yuxiang Dong, Sohan Mahto, Virender Kumar, Donald R Ronning, Ram I Mahato
A novel phosphodiesterase inhibitor for the treatment of chronic liver injury and metabolic diseases. Hepatology (Baltimore, Md.) (2024)
Rongguo Ren, Xiaofang Wang, Derek A Leas, Christian Scheurer, Sarah Hoevel, Monica Cal, Gong Chen, Longjin Zhong, Kasiram Katneni, Thao Pham, Rahul Patil, Diptesh Sil, Matthias J Walters, Thomas T Schulze, Andrew J Neville, Yuxiang Dong, Sergio Wittlin, Marcel Kaiser, Paul H Davis, Susan A Charman, Jonathan L Vennerstrom
Antimalarial Dibenzannulated Medium-Ring Keto Lactams. ACS infectious diseases (2023)
Ghizal Siddiqui, Carlo Giannangelo, Amanda De Paoli, Anna Katharina Schuh, Kim C Heimsch, Dovile Anderson, Timothy G Brown, Christopher A MacRaild, Jianbo Wu, Xiaofang Wang, Yuxiang Dong, Jonathan L Vennerstrom, Katja Becker, Darren John Creek
Peroxide Antimalarial Drugs Target Redox Homeostasis in Plasmodium falciparum Infected Red Blood Cells. ACS infectious diseases 8 (1) (2022)
Yuxiang Dong, Yogesh Sonawane, Steven P Maher, Anne-Marie Zeeman, Victor Chaumeau, Amélie Vantaux, Caitlin A Cooper, Francis C K Chiu, Eileen Ryan, Jenna McLaren, Gong Chen, Sergio Wittlin, Benoît Witkowski, François Nosten, Kamaraj Sriraghavan, Dennis E Kyle, Clemens H M Kocken, Susan A Charman, Jonathan L Vennerstrom
Metabolic, Pharmacokinetic, and Activity Profile of the Liver Stage Antimalarial (RC-12). ACS omega 7 (14) (2022)
David M Shackleford, Francis C K Chiu, Kasiram Katneni, Scott Blundell, Jenna McLaren, Xiaofang Wang, Lin Zhou, Kamaraj Sriraghavan, André M Alker, Daniel Hunziker, Christian Scheurer, Qingjie Zhao, Yuxiang Dong, Jörg J Möhrle, Nada Abla, Hugues Matile, Sergio Wittlin, Jonathan L Vennerstrom, Susan A Charman
Cytochrome P450-Mediated Metabolism and CYP Inhibition for the Synthetic Peroxide Antimalarial OZ439. ACS infectious diseases 7 (7) (2021)
Derek A Leas, Yuxiang Dong, Jered C Garrison, Xiaofang Wang, Edward L Ezell, Douglas E Stack, Jonathan L Vennerstrom
Tricyclic Imidazolidin-4-ones by Witkop Oxidation of Tetrahydro-β-carbolines. The Journal of organic chemistry 85 (4) (2020)
Abdulraman M Alshammari, D David Smith, Jake Parriott, Jason P Stewart, Stephen M Curran, Russell J McCulloh, Peter A Barry, Smita S Iyer, Nicholas Palermo, Joy A Phillips, Yuxiang Dong, Donald R Ronning, Jonathan L Vennerstrom, Sam D Sanderson, Joseph A Vetro
Targeted Amino Acid Substitution Overcomes Scale-Up Challenges with the Human C5a-Derived Decapeptide Immunostimulant EP67. ACS infectious diseases 6 (5) (2020)
Jianbo Wu, Xiaofang Wang, Francis C K Chiu, Cécile Häberli, David M Shackleford, Eileen Ryan, Sriraghavan Kamaraj, Vivek J Bulbule, Alexander I Wallick, Yuxiang Dong, Karen L White, Paul H Davis, Susan A Charman, Jennifer Keiser, Jonathan L Vennerstrom
Structure-Activity Relationship of Antischistosomal Ozonide Carboxylic Acids. Journal of medicinal chemistry 63 (7) (2020)
Joëlle Jourdan, Annabelle Walz, Hugues Matile, Alexander Schmidt, Jianbo Wu, Xiaofang Wang, Yuxiang Dong, Jonathan L Vennerstrom, Remo S Schmidt, Sergio Wittlin, Pascal Mäser
Stochastic Protein Alkylation by Antimalarial Peroxides. ACS infectious diseases 5 (12) (2019)

Yuxiang Dong.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Yuxiang Dong